Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.

Clinical therapeutics - 1 Jul 2016

Peters Mary Linton B, Tseng Jennifer F, Miksad Rebecca A

Abstract excerpt

PURPOSE: This article reviews the progress to date and future directions for investigation of germline and somatic genetic testing to inform pancreatic adenocarcinoma (PDAC) treatment, screening, and prevention strategies. METHODS: We searched PubMed to identify recent articles regarding genetic testing in pancreatic cancer, including both germline and somatic testing, and recent genome-wide association studies....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to ALK gene
Share to CDK4 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genome-Wide Association Study

Share to Molecular Targeted Therapy

Share to Mutation

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 27041411
DOI: 10.1016/j.clinthera.2016.03.006

Genes

ALK
BRAF
CDK4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.PMID 27041411Read ↗

An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.Semantic proximity Read ↗

Germline Aberrations in Pancreatic Cancer: Implications for Clinical CareSemantic proximity Read ↗

Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.Semantic proximity Read ↗

Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications.Semantic proximity Read ↗

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.Semantic proximity Read ↗

Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors.Semantic proximity Read ↗

A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.Semantic proximity Read ↗

Germline Pathogenic Variants in Patients with Pancreatic Ductal Adenocarcinoma and Extra-Pancreatic Malignancies: A Nationwide Database AnalysisSemantic proximity Read ↗

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as BiomarkersSemantic proximity Read ↗

Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel OpportunitiesSemantic proximity Read ↗

Hereditary Pancreatic Cancer: Advances in Genetic Testing, Early Detection Strategies, and Personalized ManagementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.